NDC 61133-0892 - Dexium-SP
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61133-0892
- Package NDCs from labels
- 61133-0892-9
- Manufacturer
- Bimeda, Inc. | Bimeda-MTC Animal Health
- Effective date
- 2025-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dexium-SP - Bimeda, Inc. | Bimeda-MTC Animal Health | Bimeda, Inc. | Bimeda-MTC Animal Health | 2025-03-19 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61133-0892-9 | Dexium-SP | 100 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 100 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61133-0892 | DEXIUM-SP (DEXAMETHASONE SODIUM PHOSPHATE) INJECTION, SOLUTION [BIMEDA, INC.] | 18 | 1 package rows | 20250322_3f6e8445-7335-4776-aa84-c34f61d43e40.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | ACTIVE INGREDIENT | AI9376Y64P | DEXIUM-SP (DEXAMETHASONE SODIUM PHOSPHATE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 5 | |
| DEXAMETHASONE | ACTIVE MOIETY | 7S5I7G3JQL | DEXIUM-SP (DEXAMETHASONE SODIUM PHOSPHATE) INJECTION, SOLUTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 8969803e-2e45-1f28-e053-2995a90a05a7 | 2023-05-15 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | bbf0f0ee-1891-4f3d-e053-2a95a90a5e18 | 2023-05-04 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 9f69846e-5897-c301-e053-2a95a90a44f1 | 2023-05-03 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 667323ea-5a5e-3465-e053-2a91aa0a1667 | 2023-04-26 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | 2d96d5e8-00bf-406b-b345-f1c31865fe94 | 2023-04-04 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | HF Acquisition Co LLC, DBA HealthFirst | 94cb045b-5801-db32-e053-2a95a90a93ef | 2022-12-10 | Warnings, Adverse reactions | AI9376Y64P |
| DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | ca762fbf-6bf5-4b39-8f40-3fb5f1f77778 | 2022-10-12 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Bausch & Lomb Incorporated | 6bdcefbe-51e3-4ca4-afda-5aeca7b6fa73 | 2022-08-31 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | b2ce414a-3b1f-4533-bb3a-18594529dead | 2020-11-25 | Warnings, Adverse reactions | AI9376Y64P |
| DMT SUIK | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | a7b7884a-6bd4-4d06-8f14-0759450c0724 | 2020-06-17 | Warnings, Adverse reactions | AI9376Y64P |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Mylan Institutional LLC | 836f8017-d023-410b-8515-ec776e73ca59 | 2019-11-04 | Warnings, Adverse reactions | AI9376Y64P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.